Twist Bioscience Corporation (HAM:0ME) Financings

Twist Bioscience Corporation

Financings

RaiseDate
Public offering of common stock
Made bigger: US$300M · US$96 a share · Goldman Sachs & Co. LLC +3
Dealers: Goldman Sachs & Co. LLC (co-lead), William Blair (co-lead), Leerink Partners (co-lead), Guggenheim Securities (co-lead)
Use of proceeds: Research and development, manufacturing capacity expansion, product offerings, working capital and general corporate purposes
Aug 5, 2026

Read by 6ix AI from the company's releases